Arrowhead Pharmaceuticals Inc (ARWR)
18.54
+0.26
(+1.42%)
USD |
NASDAQ |
Nov 22, 16:00
18.53
-0.01
(-0.05%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Total Liabilities (Quarterly): 544.78M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 544.78M |
| March 31, 2024 | 459.74M |
| December 31, 2023 | 452.57M |
| September 30, 2023 | 478.39M |
| June 30, 2023 | 413.87M |
| March 31, 2023 | 426.20M |
| December 31, 2022 | 495.12M |
| September 30, 2022 | 273.60M |
| June 30, 2022 | 277.60M |
| March 31, 2022 | 251.31M |
| December 31, 2021 | 265.98M |
| September 30, 2021 | 301.33M |
| June 30, 2021 | 298.04M |
| March 31, 2021 | 311.25M |
| December 31, 2020 | 44.78M |
| September 30, 2020 | 60.72M |
| June 30, 2020 | 63.14M |
| March 31, 2020 | 67.51M |
| December 31, 2019 | 88.07M |
| September 30, 2019 | 105.81M |
| June 30, 2019 | 111.16M |
| March 31, 2019 | 133.30M |
| December 31, 2018 | 169.45M |
| September 30, 2018 | 16.37M |
| June 30, 2018 | 11.14M |
| Date | Value |
|---|---|
| March 31, 2018 | 13.28M |
| December 31, 2017 | 18.02M |
| September 30, 2017 | 23.16M |
| June 30, 2017 | 25.54M |
| March 31, 2017 | 33.54M |
| December 31, 2016 | 47.05M |
| September 30, 2016 | 33.15M |
| June 30, 2016 | 26.11M |
| March 31, 2016 | 20.68M |
| December 31, 2015 | 19.01M |
| September 30, 2015 | 22.65M |
| June 30, 2015 | 14.45M |
| March 31, 2015 | 18.18M |
| December 31, 2014 | 16.43M |
| September 30, 2014 | 16.83M |
| June 30, 2014 | 10.82M |
| March 31, 2014 | 13.10M |
| December 31, 2013 | 11.78M |
| September 30, 2013 | 11.59M |
| June 30, 2013 | 8.182M |
| March 31, 2013 | 8.659M |
| December 31, 2012 | 7.627M |
| September 30, 2012 | 7.719M |
| June 30, 2012 | 8.039M |
| March 31, 2012 | 8.514M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
44.78M
Minimum
Dec 2020
544.78M
Maximum
Jun 2024
293.37M
Average
298.04M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Vaxcyte Inc | 142.11M |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 10.68M |
| IGC Pharma Inc | 2.992M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 883.76M |
| Shareholders Equity (Quarterly) | 330.55M |